, /PRNewswire/ -- "According to the latest BCC Research study, the demand for is expected to grow from in 2024 to by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029." This report offers a detailed summary of the polymerase chain reaction (PCR) technology for point-of-care (POC) diagnostics, including an analysis of the competitive landscape and profiles of key market players.
It examines trends, drivers, challenges, and opportunities within the market, providing insights into historical, current, and potential market sizes. The report is valuable for market players and new entrants, offering guidance on producing and licensing goods and services. It includes segmentation by product type (POC PCR analyzers, consumables) and analyte (single analyte, multi-analyte), as well as application areas like infectious diseases and sexually transmitted infections (STIs).
Geographical and country-level market analyses are provided for all major segments. The study details current market products in 2023, measures market size, and forecasts for 2029, and assesses competitors and their market shares for 2023. Please for more details about " The global market for polymerase chain reaction for point-of-care diagnostics Report".
The rise in infectious diseases, such as viral and bacterial infections, has increased the demand for rapid and accurate diagnostics. PCR-based POC diagnostics provide quick results, aiding timely intervention and infection manag.
